Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic responseAmir Fathi, Yi‐Bin Chen, Hossein Sadrzadeh et al.|Blood|2012Cited by 123
IDH1 Mutant Inhibitor Induces Cellular Differentiation and Offers a Combination Benefit With Ara-C In a Primary Human Idh1 Mutant AML Xenograft ModelKatharine Yen, Fang Wang, Hua Yang et al.|Blood|2013Cited by 13